CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Clinical trials for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CANCER TREATMENT-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to rescue cancer patients from chemotherapy side effect
Disease control Recruiting nowThis study is testing if an investigational drug called QL0911 can safely and effectively raise platelet counts in cancer patients. Low platelets, a common and serious side effect of chemotherapy, can force treatment delays. The goal is to help patients complete their planned can…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Cord blood trial aims to boost platelets in cancer patients
Disease control Recruiting nowThis study is testing if an infusion of umbilical cord blood can safely help cancer patients whose platelet counts have dropped dangerously low due to their cancer treatments. The trial will enroll 25 patients aged 12-65 to receive the cord blood infusion and then track their pla…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC